Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Oncology | Pathology | Journal

Back to Journal Articles

Cancer ‘Stem Cells’ Identified in Different Tumors

Last Updated: August 01, 2012.

 

Three studies show small population of cells able to propagate tumors, support stem cell hypothesis

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
A small population of cancer cells seem able to propagate cancer cell growth, in solid tumors and in intestinal adenomas, according to two studies published online Aug. 1 in Nature and a third study also published online Aug. 1 in Science.

WEDNESDAY, Aug. 1 (HealthDay News) -- A small population of cancer cells seem able to propagate cancer cell growth, in solid tumors and in intestinal adenomas, according to two studies published online Aug. 1 in Nature and a third study also published online Aug. 1 in Science.

Jian Chen, Ph.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined how recurrence occurs in a genetically engineered mouse model of glioblastoma. The researchers found that, on arrest of tumor cell proliferation with temozolomide, a subset of endogenous tumor cells were identified as the source of new tumor growth. In a second study, Gregory Driessens, Ph.D., from the Université Libre de Bruxelles, and colleagues used genetic labeling to mark and trace individual squamous skin tumor cells at different stages in progression. While the majority of cells in benign papilloma had a limited proliferative potential, the researchers found that a fraction of the cells had the capacity to persist in the long term. These cells gave rise to progeny that comprised a considerable part of the tumor.

In a third study, Arnout G. Schepers, from the Hubrecht Institute in Utrecht, Netherlands, and colleagues used lineage retracing to examine the cancer stem cell hypothesis in a mouse model of primary intestinal adenomas. The researchers found that the crypt stem cell marker (Lgr5) marked a subpopulation of adenoma cells, representing about 5 to 10 percent of the cells in an adenoma. This subpopulation generated additional Lgr5+ cells and all other adenoma cell types.

"Combined with the observation that large parts of an adenoma can emerge from a single Lgr5+ adenoma cell, these observations qualify these cells as the multipotent stem cells of the adenoma," Schepers and colleagues write.

Abstract - Chen
Full Text (subscription or payment may be required)
Abstract - Driessens
Full Text (subscription or payment may be required)
Abstract - Schepers
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Men With Prostate Cancer Increasingly Don't Die From It Next: Chemo Combo Ups Survival in Metastatic Breast Cancer

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.